New drugs associated with a 29% reduction in cancer deaths in Spain in a single year

A study by Professor Lichtenberg of Columbia University attributes up to 96% of the increase in life expectancy in cancer patients and a high degree of cost-effectiveness to the new drugs Source: abc.es A study by Professor Lichtenberg, from Columbia University, attributes up to 96% of the increase in life expectancy in cancer patients and […]

Europe is losing weight in R&D investment in new drugs in the face of US and China’s drive

A report by the European Federation of the Pharmaceutical Industry (Efpia) insists that our continent has lost 25% of its weight in this area in the last 20 years This loss of European competitiveness has a direct implication for citizens, with less access to new medicines or the possibility of participating in innovative clinical trials […]

“There must be a national commitment for Spain to remain at the forefront of clinical research”.

Increased international competitiveness and digitalisation will require more investment in infrastructure and resources to ensure that our country remains at the forefront of biomedical R&D Source: farmaindustria.es Today, a quality healthcare system is inconceivable without solid research activity, and it is the foundation on which a modern society must be built. This is because clinical […]

Multiple sclerosis patients interested in clinical trials

Farmaindustria explains to Esclerosis Múltiple Euskadi what these studies consist of, how to take part in them and how research into this pathology is progressing Source: farmaindustria.es The involvement of patients in the entire process of research, development and approval of new medicines is a need that is increasingly accepted by all actors in the […]

The pharmaceutical industry leads the world in R&D investment: it now exceeds 200 billion a year

Aerospace and defence investment is eight times higher than in the aerospace and defence industry, seven times higher than in the chemical industry, and twice as high as in the IT industry. A report by the International Federation of Pharmaceutical Industries predicts that investment will continue to grow by more than 4% a year in […]

Biomedical R&D advances in the aftermath of the pandemic: the pharmaceutical industry has 8,000 drugs under investigation, 10% of them for rare diseases

Oncology, infectious diseases, neurology, haematology and endocrinology are the areas with the highest number of clinical trials with new treatments underway. Seven out of ten molecules in clinical trials worldwide are first-in-class, i.e. break new ground. The European Federation of the Pharmaceutical Industry warns that Europe’s share of biomedical R&D is declining and already lags […]

Argentinean health authorities and pharmaceutical industry are interested in the keys to Spain’s leadership in clinical research

Farmaindustria explains to some twenty experts some of the policies and initiatives that have made Spain an international benchmark in clinical drug trials Source: farmaindustria.es Representatives of provincial health authorities and the Argentine Chamber of Medicinal Specialities (Caeme) visited Farmaindustria’s headquarters on Tuesday to learn first-hand about Spain’s successful model of clinical research, based on […]

More training and information to move towards excellence in clinical trials in Spain

Farmaindustria organises workshops with representatives of the Spanish Data Protection Agency and the Spanish Medicines Agency to continue working on the implementation of the new Code of Conduct regulating the processing of personal data and the Clinical Trials Regulation Source: farmaindustria.es In recent years, Spain has become a world leader in clinical trials, thanks to […]

Farmaindustria highlights the consolidation of Spain’s leadership in biomedical R&D, within the Strategic Plan of the Pharmaceutical Industry

In the framework of its General Assembly, held in Madrid Source: www.actasanitaria.com In the framework of its General Assembly, held in Madrid, Farmaindustria has highlighted, this Thursday, 23 June, access to innovation, strengthening production and consolidating Spain’s leadership in biomedical R&D as the basis for the Strategic Plan for the Pharmaceutical Industry. “We should be […]

How research into new medicines changes people’s lives

Representatives of patients’ associations, researchers and experts in health economics debate in the newspaper El Español on the link between health, the economy and the well-being of society. Source: www.farmaindustria.es Medicines have become the essential instrument of modern healthcare systems in the fight against disease and health care. This was made clear at a symposium […]